Home » Clinical Trials » Solid tumors » NCT06208878
NCT06208878

A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies

Study Summary

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

Want to learn more about this trial?

Request More Info

Interventions

Non InterventionalOTHER
Safety and Efficacy Assessment

Study Locations

FacilityCityStateCountry
City of HopeDuarteCaliforniaUnited States
Cedars SinaiLos AngelesCaliforniaUnited States
StanfordStanfordCaliforniaUnited States
Yale New Haven HospitalNew HavenConnecticutUnited States
EmoryAtlantaGeorgiaUnited States
University of ChicagoChicagoIllinoisUnited States
University of KansasWestwoodKansasUnited States
University of MinnesotaMinneapolisMinnesotaUnited States
Washington University Saint LouisSt LouisMissouriUnited States
MSKCCNew YorkNew YorkUnited States
Montefiore Medical CenterThe BronxNew YorkUnited States
Oregon Health and Science UniversityPortlandOregonUnited States
University of PennsylvaniaPhiladelphiaPennsylvaniaUnited States
UT SouthwesternDallasTexasUnited States
MD Anderson Cancer CenterHoustonTexasUnited States
Methodist Hospital-Sarah CannonSan AntonioTexasUnited States
University of Utah-Huntsman Cancer InstituteSalt Lake CityUtahUnited States
Royal Prince Alfred HospitalCamperdownNew South WalesAustralia
Peter MacCallum Cancer CenterMelbourneVictoriaAustralia
Sir Charles GairdnerNedlandsAustralia
Princess MargaretTorontoOntarioCanada
University Hospital Hamburg-EppendorfHamburgGermany

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026